Dementia as primary symptom in late onset multiple sclerosis. Case series and review of the literature;Demenz als erstsymptom bei spät beginnender multipler sklerose. Fallserie mit literaturübersicht

Nervenarzt

Volumn 76, Issue 6, 2005, Pages 748-755

  Leyhe, T ^a   Laske, C ^a   Buchkremer, G ^a   Wormstall, H ^a   Wiendl, H ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cognitive impairment; Dementia; Late onset; Multiple sclerosis

Indexed keywords

CLINICAL FEATURE; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DEMENTIA; DIFFERENTIAL DIAGNOSIS; GAIT DISORDER; GERIATRIC PATIENT; HUMAN; MENTAL HEALTH CENTER; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; PROGNOSIS; REVIEW; SYMPTOMATOLOGY;

AGE OF ONSET; AGED; COGNITION DISORDERS; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 21644457441     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-004-1814-4     Document Type: Review

References (39)

1. Achiron A, Barak Y (2003) Cognitive impairment in probable multiple sclerosis. J Neurol Neurosurg Psychiatry 74:443-446
2. Andreasen N, Minthon L, Davidsson P et al. (2001) Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice. Arch Neurol 58:373-379
3. Arai H, Morikawa Y, Higuchi M et al. (1997) Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology. Biochem Biophys Res Commun 236:262-264
4. Azzimondi G, Stracciari A, Rinaldi R et al. (1994) Multiple sclerosis with very late onset. Report of six cases and review of the literature. Eur Neurol 34:332-336
5. Bartosik-Psujek H, Archelos JJ (2004) Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthese of IgG. J Neurol 251:414-420
6. Benedict RH, Weinstock-Guttman B, Fishman I (2004) Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 61 (2):226-230
7. Bo L, Vedeler CA, Nyland HI et al. (2003) Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 62 (7):723-732
8. Börner RJ, Kapfhammer HP (1999) Psychopathological changes and cognitive impairment in encephalomyelitis disseminata. Eur Arch Psychiatry Clin Neurosci 249:96-102
9. Bruck W, Lucchinetti C, Lassmann H (2002) The pathology of primary progressive multiple sclerosis. Mult Scler 8:93-97
10. Confavreux C, Aimard G, Devic M (1980) Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain 103 (2):281-300
11. Delalande S, De Seze J, Ferriby D et al. (2002) Late onset multiple sclerosis. Rev Neurol 158 (11):1082-1087
12. Dehmeshki J, Chard DT, Leary SM et al. (2003) The normal appearing grey matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study. J Neurol 250 (1):67-74
13. Fazekas F, Offenbacher H, Fuchs S et al. (1988) Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology 38:1822-1825
14. Fisher E, Rudick RA, Simon JH et al. (2002) Eight-year follow-up study of brain atrophy in patients with MS. Neurology 59 (9):1412-1420
15. Fischer JS, Priore RL, Jacobs LD et al. (2000) Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Ann Neurol 48 (6):885-892
16. Hampel H, Kötter HU, Padberg F et al. (1999) Oligoclonal bands and blood-cerebrospinal-fluid barrier dysfunction in a subset of patients with Alzheimer Disease: comparison with vascular dementia, major depression, and multiple sclerosis. Alzheimer Dis Assoc Disord 13:9-19
17. Hooge JP, Redekop WK (1992) Multiple sclerosis with very late onset. Neurology 42:1907-1910
18. Jiménez-Jiménez FJ, Zurdo JM, Hernanz A et al. (2002) Tau protein concentrations in cerebrospinal fluid of patients with multiple sclerosis. Acta Neural Scand 106:351-354
19. Kapaki E, Paraskevas GP, Michalopoulou M et al. (2000) Increased cerebrospinal fluid tau protein in multiple sclerosis. Eur Neurol 43:228-232
20. Knopman DS, De Kosky ST, Cummings JL et al. (2001) Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56:1143-1153
21. Kuhlmann T, Lingfeld G, Bitsch A et al. (2002) Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125:2202-2212
22. Lyon-Caen O, Izquierdo G, Marteau R et al. (1985) Late onset multiple sclerosis. A clinical study of 16 pathologically proven cases. Acta Neurol Scand 72:56-60
23. Marra T (1984) Multiple sclerosis with onset after age 60. J Am Geriatr Soc 32:16-18
24. Mc Donald WI, Compston A, Edan G et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121-127
25. Morris JC, Heyman A, Mohs RC et al. (1989) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39:1159-1165
26. Noseworthy JH, Lucchinitti C, Rodriguez M et al. (2000) Multiple sclerosis. N Engl J Med 343:938-952
27. Noseworthy J, Paty D, Wonnacott T et al. (1983) Multiple sclerosis after age 50. Neurology 33:1537-1544
28. Pelletier D, Garrison K, Henry R (2004) Measurement of whole-brain atrophy in multiple sclerosis. J Neuroimaging 14 [3 Suppl]:11S-19S
29. Polliack ML, Barak Y, Achiron A (2001) Late-onset multiple sclerosis. J Am Geriatr Soc 49:168-171
30. Poser CM, Paty DW, Scheinberg L et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231
31. Rao SM, Leo GJ, Bernardin L et al. (1991) Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 41 (5):685-691
32. Rao SM, Leo GJ, Ellington L et al. (1991) Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 41 (5):692-696
33. Thompson AJ, Montalban X, Barkhof F et al. (2000) Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 47:831-835
34. Weinshenker BG, Bass B, Rice GPA et al. (1989) The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 112:133-146
35. Weinstein A, Schwid SIL, Schiffer RB et al. (1999) Neuropsychologcal status in MS after treatment with glatiramer acetate (Copaxone). Arch Neurol 56:319-324
36. White AD, Swingler RJ, Compston DAS (1990) Features of multiple sclerosis in older patients in South Wales. Gerontology 36:159-164
37. Wiendl H, Melms A, Hohlfeld R (2003) Multiple Sklerose und andere demyelinisierende Erkrankungen. In: Brandt T, Dichgans J, Diener H-C (Hrsg) Therapie und Verlauf neurologischer Erkrankungen, 4. Aufl. Kohlhammer, Stuttgart, S 610-663
38. Zarei M, Chandran S, Compston A et al. (2003) Cognitive presentation of multiple sclerosis: evidence for a cortical variant. J Neurol Neurosurg Psychiatry 74:872-877
39. Zivadinov R, Bakshi R (2004) Role of MRI in multiple sclerosis II: brain and spinal cord atrophy. Front Biosci 9:647-64